James Fessenden

Subscribe to RSS - James Fessenden

Expanded newborn screening offers early diagnosis, treatment of infants with SCID

Using population-based screening outcomes of approximately 3 million infants, a team of scientists across 14 states, including four researchers at UMass Medical School, have shown that newborn screening for severe combined immunodeficiency (SCID) can be successfully implemented across public health newborn screening programs. Data from 11 newborn screening programs published in the Aug. 20 issue of the Journal of the American Medical Association (JAMA) showed the rate of SCID in newborns is higher than previously thought and believed to be 1 in 58,000.